Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pierre Berger

Showing results (31-40 of 33) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 33 results.
The Journal of International Medical Research|June 24, 2021
A prospective, observational study of fidaxomicin use for <i>Clostridioides difficile</i> infection in FranceBenoit Guery, Pierre Berger, Remy Gauzit, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|March 3, 2024
Characteristics and incidence of infections in patients with multiple myeloma treated by bispecific antibodies: a national retrospective studyAurélie Jourdes, Elise Cellerin, Cyrille Touzeau, et al.
Annals of Hematology|January 9, 2025
Trends in the epidemiology of intravascular device-associated bacteremia among French hematology patients: insights from the SPIADI prospective multicenter study, 2020-2024Nathalie van der Mee-Marquet, Pierre Berger, Maris Dussartre, et al.
Pageof 4

Showing results (31-40 of 33) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 33 results.
The Journal of International Medical Research|June 24, 2021
A prospective, observational study of fidaxomicin use for <i>Clostridioides difficile</i> infection in FranceBenoit Guery, Pierre Berger, Remy Gauzit, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|March 3, 2024
Characteristics and incidence of infections in patients with multiple myeloma treated by bispecific antibodies: a national retrospective studyAurélie Jourdes, Elise Cellerin, Cyrille Touzeau, et al.
Annals of Hematology|January 9, 2025
Trends in the epidemiology of intravascular device-associated bacteremia among French hematology patients: insights from the SPIADI prospective multicenter study, 2020-2024Nathalie van der Mee-Marquet, Pierre Berger, Maris Dussartre, et al.
Pageof 4